44
Pereira
Pinto
L, de
Souza
LB, Gordón-Núñez
MA, et al. Prevention of oral lesions in children with acute
lymphoblastic leukemia.
Int J Pediatr
Otorhinolaryngol. 2006; 70(11):
1847-51.
45
Chi
AC, Neville
BW, Krayer
JW, Gonsalves
WC. Oral manifestations of systemic disease.
American Fam
Physi. 2010; 82(11):1381-88.
46 Romeo O, Criseo G. Molecular epidemiology of Candida albicansand its closely related yeasts Candida dubliniensis andCandida africana . J Clin Microbiol. 2009; 47:212-4.
47 Romeo O, Criseo G. Candida africana and its closest
relatives. Mycoses. 2011; 54:475-86.
48 Romeo O, Criseo G. First molecular method for discriminating betweenCandida africana, Candida albicans and Candida dubliniensis by
using hwp1 gene. Diagn Microbiol Infect Dis. 2008; 6:230-3.
49 Odds FC. Molecular phylogenetics and epidemicology of Candida
albicans. Future Microbiol. 2010; 5:67-79.
50 Criseo G, Scordino F, Romeo O. Current methods for identifying
clinically important cryptic Candida species. J Microbiol Methods
2015; 111:50-56.
51 Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC.Candida dubliniesis sp. nov. : Phenotypic and molecular
characterization of a novel species associated with oral candidiasis in
HIV-infected individuals. Microbiology. 1995; 141:1507-21.
52 Marsh PD, Martin M. “Oral fungal infections”, in Orals
Microbiology, Churchill Livingstone, Edinburgh, UK; 2009. pp. 166-179.